These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203 [TBL] [Abstract][Full Text] [Related]
50. Recent progress in sodium channel modulators for pain. Bagal SK; Chapman ML; Marron BE; Prime R; Storer RI; Swain NA Bioorg Med Chem Lett; 2014 Aug; 24(16):3690-9. PubMed ID: 25060923 [TBL] [Abstract][Full Text] [Related]
51. Reliable identification of cardiac conduction abnormalities in drug discovery using automated patch clamp II: Best practices for Nav1.5 peak current in a high throughput screening environment. Rotordam MG; Obergrussberger A; Brinkwirth N; Takasuna K; Becker N; Horváth A; Goetze TA; Rapedius M; Furukawa H; Hasegawa Y; Oka T; Fertig N; Stoelzle-Feix S J Pharmacol Toxicol Methods; 2021; 112():107125. PubMed ID: 34500078 [TBL] [Abstract][Full Text] [Related]
52. Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity. Stueber T; Eberhardt MJ; Hadamitzky C; Jangra A; Schenk S; Dick F; Stoetzer C; Kistner K; Reeh PW; Binshtok AM; Leffler A Anesthesiology; 2016 May; 124(5):1153-65. PubMed ID: 26859646 [TBL] [Abstract][Full Text] [Related]
53. Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT. Bridgland-Taylor MH; Hargreaves AC; Easter A; Orme A; Henthorn DC; Ding M; Davis AM; Small BG; Heapy CG; Abi-Gerges N; Persson F; Jacobson I; Sullivan M; Albertson N; Hammond TG; Sullivan E; Valentin JP; Pollard CE J Pharmacol Toxicol Methods; 2006; 54(2):189-99. PubMed ID: 16563806 [TBL] [Abstract][Full Text] [Related]
54. Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat. Wang CF; Gerner P; Schmidt B; Xu ZZ; Nau C; Wang SY; Ji RR; Wang GK Anesth Analg; 2008 Oct; 107(4):1397-405. PubMed ID: 18806059 [TBL] [Abstract][Full Text] [Related]
55. Sodium channel inhibitor drug discovery using automated high throughput electrophysiology platforms. Castle N; Printzenhoff D; Zellmer S; Antonio B; Wickenden A; Silvia C Comb Chem High Throughput Screen; 2009 Jan; 12(1):107-22. PubMed ID: 19149496 [TBL] [Abstract][Full Text] [Related]
56. Ion channel recordings on an injection-molded polymer chip. Tanzi S; Matteucci M; Christiansen TL; Friis S; Christensen MT; Garnaes J; Wilson S; Kutchinsky J; Taboryski R Lab Chip; 2013 Dec; 13(24):4784-93. PubMed ID: 24154831 [TBL] [Abstract][Full Text] [Related]
57. The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7. McPate M; Bhalay G; Beckett M; Fairbrother S; Gosling M; Groot-Kormelink PJ; Lane R; Kent T; Van Diepen MT; Tranter P; Verkuyl JM Assay Drug Dev Technol; 2014 Jun; 12(5):282-92. PubMed ID: 24906109 [TBL] [Abstract][Full Text] [Related]
58. Phenethyl nicotinamides, a novel class of Na(V)1.7 channel blockers: structure and activity relationship. Kers I; Macsari I; Csjernyik G; Nylöf M; Skogholm K; Sandberg L; Minidis A; Bueters T; Malmborg J; Eriksson AB; Lund PE; Venyike E; Luo L; Nyström JE; Besidski Y Bioorg Med Chem Lett; 2012 Oct; 22(19):6108-15. PubMed ID: 22939696 [TBL] [Abstract][Full Text] [Related]
59. Block of human NaV1.5 sodium channels by novel alpha-hydroxyphenylamide analogues of phenytoin. Lenkowski PW; Ko SH; Anderson JD; Brown ML; Patel MK Eur J Pharm Sci; 2004 Apr; 21(5):635-44. PubMed ID: 15066664 [TBL] [Abstract][Full Text] [Related]
60. Validation and optimization of novel high-throughput assays for human epithelial sodium channels. Chen MX; Gatfield K; Ward E; Downie D; Sneddon HF; Walsh S; Powell AJ; Laine D; Carr M; Trezise D J Biomol Screen; 2015 Feb; 20(2):242-53. PubMed ID: 25278498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]